Intravenous infusion of prostaglandin E1 therapy in extremity ischemia
Prostaglandins are potent vasoactive agents with wide variety of other actions - vasodilatation, fibrinolysis and inhibition of platelet aggregation. PGE1 was the agent used since 1973 for cardiovascular diseases, mainly in patients with advanced PVD. PGE1 intra venous infusion has shown to be benef...
Main Author: | Pinjala Ramakrishna |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Indian Journal of Vascular and Endovascular Surgery |
Subjects: | |
Online Access: | http://www.indjvascsurg.org/article.asp?issn=0972-0820;year=2017;volume=4;issue=2;spage=38;epage=42;aulast=Ramakrishna |
Similar Items
-
Protective Effects of N-acetylcysteine and a Prostaglandin E1 Analog, Alprostadil, Against Hepatic Ischemia: Reperfusion Injury in Rats
by: Cheng-Chu Hsieh, et al.
Published: (2014-01-01) -
Prostaglandin research /
by: Crabbe, Pierre
Published: (1977) -
Prostaglandins and related substances/
by: Pace-Asciak, C., et al.
Published: (1983) -
Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension
by: Cheng Zeng, et al.
Published: (2023-11-01) -
Ischemic preconditioning vs adenosine vs prostaglandin E1 for protection against liver ischemia/reperfusion injury
by: M. Radojkovic, et al.